C. Subashini, L.J. Kennedy and F.V. Singh
Journal of Molecular Structure 1226 (2021) 129365
2.2.4.8. Tert–butyl 8-(4-bromophenyl)-5-cyano-6-(4-phenylpiperazin-
1-yl)-3,4-dihydroquinoline-1(2H)-carboxylate 9h. Colourless solid;
yield: 84%; mp: 160–162 °C; 1H NMR (400 MHz, CDCl3): δ = 0.93–
1.11 (m, 9H, CH3), 1.43 (s, 2H, CH2), 1.69–1.95 (m, 1H, CH2),
1.99–2.29 (m, 1H, CH2), 2.43–2.75 (m, 1H, CH2), 3.11–3.46 (m,
8H, NCH2), 3.79–4.49 (m, 1H, CH2), 6.78 (s, 1H, ArH), 6.82 (t,
J = 8.0 Hz, 1H, ArH), 6.91 (d, J = 8.0 Hz, 2H, ArH), 7.22 (t,
J = 8.0 Hz, 4H, ArH), 7.41–7.59 (m, 2H, ArH) ppm;13C {1H} NMR
(101 MHz, CDCl3): δ = 23.8, 26.1, 27.6, 28.4, 43.05, 49.6, 51.9, 80.9,
116.5, 116.7, 118.2, 120.2, 123.5, 125.3, 129.2, 129.5, 130.3, 131.7,
131.9, 140.7, 151.1, 153.5 ppm IR (KBr): 2219 cm−1 (CN), 1694 cm−1
(C=O); 1507 cm−1 (C=C), 1222 cm−1 (C–N), 1049 cm−1 (C–O); MS
(EI): m/z = 575 [M + 1]+, 577 [M + 3]+; Anal. for C31H33BrN4O2:
C, 64.92; H, 5.80; N, 9.77. Found C, 64.66; H, 5.71; N, 9.51%.
128.2, 131.2, 132.7, 133.5, 137.2, 140.4, 142.6, 155.0 ppm; IR (KBr):
2213 cm−1 (CN), 1692 cm−1 (C=O), 1591 cm−1 (C=C), 1243 cm−1
(C–N), 1049 cm−1 (C–O); MS (EI): m/z = 468 [M + 1]+; Anal. for
C30H33N3O2: C, 77.06; H, 7.11; N, 8.99; Found C, 77.43; H, 6.99; N,
8.76%.
2.2.4.13. Tert–butyl
5-cyano-8-(naphthalen-1-yl)−6-(piperidin-1-
yl)−3,4-dihydroquinoline-1(2H)-carboxylate 9m. Colourless solid;
yield: 76%; mp: 175–177 °C; 1H NMR (400 MHz, CDCl3): δ = 0.41–
1.11 (m, 9H, CH3), 1.40–1.59 (m, 2H, CH2), 1.61–1.94 (m, 5H,
CH2), 2.02–2.38 (m, 1H, CH2), 2.43–2.79 (m, 1H, CH2), 2.88–
3.29 (m, 6H, NCH2), 3.61–4.35 (m, 1H, CH2), 6.69–7.01 (m, 1H,
ArH), 7.21–7.67 (m, 5H, ArH), 7.68–7.97 (m, 2H, ArH) ppm; 13C
{1H} NMR (101 MHz, CDCl3): δ = 24.1, 26.2, 27.6, 43.7, 53.4,
79.2, 104.4, 107.4, 109.9, 114.7, 117.3, 119.3, 121.7, 125.0, 125.7,
126.4,127.3, 127.9, 128.5, 132.4, 139.9, 142.7, 155.3 ppm; IR (KBr):
2214 cm−1 (CN), 1690 cm−1 (C=O), 1589 cm−1 (C=C), 1233 cm−1
(C–N), 1048 cm−1 (C–O); MS (EI): m/z = 468 [M + 1]+; Anal. for
C30H33N3O2: C, 77.06; H, 7.11; N, 8.99; Found C, 77.27; H, 7.03; N,
8.75%.
2.2.4.9. Tert–butyl
5-cyano-8-(3,4-dichlorophenyl)-6-(4-
9i.
phenylpiperazin-1-yl)-3,4-dihydroquinoline-1(2H)-carboxylate
Colourless solid; yield: 81%; mp: 158–160 °C; 1H NMR (400 MHz,
CDCl3): δ = 1.11 (s, 9H, CH3), 1.61 (s, 1H, CH2), 1.69–2.18 (m, 2H,
CH2), 2.69–3.12 (m, 2H, CH2), 3.14–3.46 (m, 8H, NCH2), 3.73–4.45
(m, 1H, CH2), 6.64 (s, 1H, ArH), 6.82 (t, J = 8.0 Hz, 1H, ArH), 6.90
(d, J = 8.0 Hz, 2H, ArH), 7.11–7.47 (m, 5H, ArH) ppm;13C {1H}
NMR (101 MHz, CDCl3): δ = 23.7, 26.2, 27.8, 44.6, 49.6, 51.9, 80.7,
106.0, 107.9, 116.4, 116.5, 118.3, 120.2, 127.1, 128.2 129.2, 133.8,
136.9, 140.5, 143.7, 151.2, 153.5 ppm; IR (KBr): 2215 cm−1 (CN),
1691 cm−1 (C=O); 1586 cm−1 (C=C), 1232 cm−1 (C–N), 1049 cm−1
(C–O); MS (EI): m/z = 565 [M + 1]+; Anal. for C31H32Cl2N4O2: C,
66.07; H, 5.72; N, 9.94; Found C, 66.29; H, 5.35; N, 10.13%.
2.2.4.14. Tert–butyl
5-cyano-8-(naphthalen-2-yl)−6-(4-
9n.
phenylpiperazin-1-yl)−3,4-dihydroquinoline-1(2H)-carboxylate
Colourless solid; yield: 73%; mp: 134–136 °C; 1H NMR (400 MHz,
CDCl3): δ = 0.61–0.98 (m, 9H, CH3), 1.50 (s, 2H, CH2), 1.74–2.06
(m, 1H, CH2), 2.14–2.86 (m, 2H, CH2), 3.17–3.50 (m, 8H, NCH2),
3.97–4.62 (m, 1H, CH2), 6.82 (t, J = 8.0 Hz, 1H, ArH), 6.87–7.03
(m, 3H, ArH), 7.22 (t, J = 8.0 Hz, 2H, ArH), 7.36–7.52 (m, 3H,
ArH), 7.70–7.89 (m, 4H, ArH) ppm; 13C {1H} NMR (101 MHz,
CDCl3): δ = 23.9, 26.2, 27.4, 28.5, 49.6, 51.9, 80.7,104.7, 116.5,
116.8, 118.7, 120.1, 125.8, 126.5, 126.6, 127.7, 127.8, 128.1, 128.4,
129.2, 132.1, 132.8, 133.5, 142.8, 145.8, 151.2, 153.5 ppm; IR (KBr):
2206 cm−1 (CN), 1692 cm−1 (C=O), 1591 cm−1 (C=C), 1232 cm−1
(C–N), 1050 cm−1 (C–O); MS (EI): m/z = 545 [M + 1]+; Anal. for
C35H36N4O2 : C, 77.18; H, 6.66; N, 10.29;. Found C, 77.09; H, 6.29;
N, 10.04%
2.2.4.10. Tert–butyl
5-cyano-6-(piperidin-1-yl)−8-(p-tolyl)−3,4-
dihydroquinoline-1(2H)-carboxylate 9j. Colourless solid; yield:
69%; mp: 154–156 °C; 1H NMR (400 MHz, CDCl3): δ = 0.74–1.08
(m, 9H, CH3), 1.46–1.58 (m, 2H, CH2), 1.63–1.75 (m, 4H, NCH2),
1.76–1.86 (m, 2H, CH2), 2.06–2.17 (m, 1H, CH2), 2.29 (s, 3H, CH3),
2.52–2.66 (m, 1H, CH2), 2.94–3.17 (m, 4H, NCH2), 3.52–3.77 (m,
1H, CH2), 4.01–4.40 (m, 1H, CH2), 6.77 (s, 1H, ArH), 7.09–7.18 (m,
2H, ArH), 7.21–7.31 (m, 2H, ArH) ppm; 13C {1H} NMR (101 MHz,
CDCl3): δ = 21.1, 24.0, 24.1, 26.2, 27.5, 42.9, 53.5, 68.0, 80.5,
104.2, 117.1, 118.3, 127.7, 129.3, 131.0, 136.6, 137.8, 140.4, 142.6,
153.6, 154.9 ppm; IR (KBr): 2214 cm−1 (CN), 1691 cm−1 (C=O);
1586 cm−1 (C=C), 1232 cm−1 (C–N), 1049 cm−1 (C–O); MS (EI):
m/z = 433 [M + 1]+; Anal. for C27H33N3O2: C, 75.14; H, 7.71; N,
9.74; Found C, 74.85; H, 8.11; N, 9.53%.
ꢀ
2.2.4.15. Tert–butyl-8-([1,1 -biphenyl]−4-yl)−5-cyano-6-(piperidin-
1-yl)−3,4-dihydroquinoline-1(2H)-carboxylate 9o. Colourless solid;
yield: 75%; mp: 212–214 °C; 1H NMR (400 MHz, CDCl3): δ = 0.79–
1.19 (m, 9H, CH3), 1.46–1.61 (m, 2H, CH2), 1.62–1.89 (m, 5H, CH2),
2.02–2.39(m, 1H, CH2), 2.49–2.78 (m, 1H, CH2), 2.90–3.24 (m,
6H, NCH2),4.26– 4.59(m, 1H, CH2), 6.83 (s, 1H, ArH), 7.26–7.33
(m, 1H, ArH), 7.33–7.47 (m, 4H, ArH), 7.48–7.65 (m, 4H, ArH)
ppm; 13C {1H} NMR (101 MHz, CDCl3): δ = 23.9, 24.1, 26.1, 26.2,
27.5, 43.1, 53.5, 80.7, 104.0, 117.0, 118.3, 127.0, 127.4, 127.5, 128.3,
128.9, 131.0, 131.1, 131.05, 140.9, 142.2, 153.6, 154.9 ppm; IR (KBr):
2209 cm−1 (CN), 1715 cm−1 (C=O), 1589 cm−1 (C=C), 1233 cm−1
(C–N), 1049 cm−1 (C–O); MS (EI): m/z = 494 [M + 1]+; Anal. for
C32H35N3O2: C, 77.86; H, 7.15; N, 8.51. Found C, 77.53; H, 7.01; N,
8.19%
2.2.4.11. Tert–butyl
5-cyano-7-methyl-8-phenyl-6-(piperidin-1-
yl)−3,4-dihydroquinoline-1(2H)-carboxylate 9k. Colourless solid;
yield: 72%; mp: 177–179 °C; 1H NMR (400 MHz, CDCl3): δ = 1.10
(s, 9H, 3CH3), 1.45–1.84 (m, 2H, CH2), 1.91–2.19 (m, 6H, CH2), 2.96
(m, 3H, CH3), 3.14 (s, 2H, CH2), 3.56–3.92 (m, 6H, 3NCH2), 6.78 (s,
1H, ArH), 7.22–7.36 (m, 3H, ArH) ppm; 13C {1H} NMR (101 MHz,
CDCl3): δ = 16.6, 23.7, 25.5, 27.8, 31.6, 44.6, 50.6, 67.8, 80.6, 109.7,
117.0, 127.8, 129.2, 133.0, 133.4, 134.2, 135.5, 136.0, 136.5, 143.7,
150.6, 152.7 ppm; IR (KBr): 2214 cm−1 (CN), 1692 cm−1 (C=O);
1591 cm−1 (C=C), 1232 cm−1 (C–N), 1049 cm−1 (C–O); MS (EI):
m/z = 467 [M + 1]+; Anal. for C27H32ClN3O2: C, 69.59; H, 7.05; N,
9.02. Found C, 69.19; H, 6.88; N, 8.91%.
ꢀ
2.2.4.16. Tert–butyl 8-([1,1 -biphenyl]−4-yl)−5-cyano-6-morpholino-
3,4-dihydroquinoline-1(2H)-carboxylate 9p. Colourless solid; yield:
75%; mp: 192–194 °C; 1H NMR (400 MHz, CDCl3): δ = 0.74–1.15
(m, 9H, CH3), 1.15–1.52 (m, 1H, CH2), 1.63–1.95 (m, 1H, CH2),
2.06–2.36 (m, 1H, CH2), 2.38–2.90 (m, 1H, CH2), 2.91–3.35 (m, 5H,
NCH2), 3.83 (s, 4H, OCH2), 3.94–4.67 (m, 1H, CH2), 6.84 (s, 1H,
ArH), 7.25–7.33 (m, 1H, ArH), 7.34–7.47 (m, 4H, ArH), 7.48–7.67 (m,
4H, ArH) ppm; 13C {1H} NMR (101 MHz, CDCl3): δ = 23.9, 26.1,
27.5, 43.1, 52.2, 67.1, 80.2, 104.8, 116.8, 118.1, 127.0, 127.5, 128.2,
128.9, 132.0, 138.3, 140.5, 140.7, 141.0, 142.4, 153.4 ppm; IR (KBr):
2214 cm−1 (CN), 1692 cm−1 (C=O), 1602 cm−1 (C=C), 1262 cm−1
(C–N), 1061 cm−1 (C–O); MS (EI): m/z = 496 [M + 1]+; Anal. for
C31H33N3O3: C, 75.13; H, 6.71; N, 8.48; Found C, 74.97; H, 6.31; N,
8.21%.
2.2.4.12. Tert–butyl
5-cyano-8-(naphthalen-2-yl)−6-(piperidin-1-
yl)−3,4-dihydroquinoline-1(2H)-carboxylate 9l. Colourless solid;
yield: 68%; mp: 172–174 °C; 1H NMR (400 MHz, CDCl3): δ = 0.39–
1.00 (m, 9H, CH3), 1.47–1.59 (m, 2H, CH2), 1.64–1.93 (m, 5H,
CH2), 1.98–2.41 (m, 1H, CH2), 2.46–2.88 (m, 1H, CH2), 2.89–3.38
(m, 6H, NCH2), 3.91–4.66 (m, 1H, CH2), 6.90 (s, 1H, ArH), 7.42
(d, J = 8.0 Hz, 3H, ArH), 7.67–7.88 (m, 4H, ArH) ppm; 13C {1H}
NMR (101 MHz, CDCl3): δ = 23.9, 24.1, 26.1, 26.2, 27.4, 43.1, 53.5,
80.5, 104.6, 117.1, 118.7, 125.8, 126.4, 127.0, 127.6, 128.0, 128.1,
4